BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24438922)

  • 1. Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.
    van Kempen BJ; Ferket BS; Kavousi M; Leening MJ; Steyerberg EW; Ikram MA; Witteman JC; Hofman A; Franco OH; Hunink MG
    Int J Cardiol; 2014 Feb; 171(3):413-8. PubMed ID: 24438922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common carotid intima-media thickness in cardiovascular risk stratification of older people: the Rotterdam Study.
    Elias-Smale SE; Kavousi M; Verwoert GC; Koller MT; Steyerberg EW; Mattace-Raso FU; Hofman A; Hoeks AP; Reneman RS; Witteman JC
    Eur J Prev Cardiol; 2012 Aug; 19(4):698-705. PubMed ID: 21697209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
    Wannamethee SG; Shaper AG; Lennon L; Morris RW
    Arch Intern Med; 2005 Dec 12-26; 165(22):2644-50. PubMed ID: 16344423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study.
    Majed B; Tafflet M; Kee F; Haas B; Ferrieres J; Montaye M; Ruidavets JB; Arveiler D; Yarnell J; Amouyel P; Ducimetiere P; Empana JP;
    Prev Med; 2013 Jul; 57(1):49-54. PubMed ID: 23603213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study.
    Koller MT; Leening MJ; Wolbers M; Steyerberg EW; Hunink MG; Schoop R; Hofman A; Bucher HC; Psaty BM; Lloyd-Jones DM; Witteman JC
    Ann Intern Med; 2012 Sep; 157(6):389-97. PubMed ID: 22986376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of first events of coronary heart disease and stroke with consideration of adiposity.
    Wilson PW; Bozeman SR; Burton TM; Hoaglin DC; Ben-Joseph R; Pashos CL
    Circulation; 2008 Jul; 118(2):124-30. PubMed ID: 18591432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study.
    Velescu A; Clara A; Peñafiel J; Ramos R; Marti R; Grau M; Dégano IR; Marrugat J; Elosua R;
    Atherosclerosis; 2015 Aug; 241(2):357-63. PubMed ID: 26071658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the Framingham point scores in the elderly: results from the Rotterdam study.
    Koller MT; Steyerberg EW; Wolbers M; Stijnen T; Bucher HC; Hunink MG; Witteman JC
    Am Heart J; 2007 Jul; 154(1):87-93. PubMed ID: 17584559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relative risk of death and life expectancy in low cardiovascular risk population].
    Zhao L; Zhou B; Li Y; Yang J; Wu Y
    Zhonghua Nei Ke Za Zhi; 2002 May; 41(5):291-4. PubMed ID: 12133418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary fiber intake and risk of cardiovascular disease in the Japanese population: the Japan Public Health Center-based study cohort.
    Kokubo Y; Iso H; Saito I; Yamagishi K; Ishihara J; Inoue M; Tsugane S;
    Eur J Clin Nutr; 2011 Nov; 65(11):1233-41. PubMed ID: 21654702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted 10-year risk of developing cardiovascular disease at the state level in the U.S.
    Yang Q; Zhong Y; Ritchey M; Loustalot F; Hong Y; Merritt R; Bowman BA
    Am J Prev Med; 2015 Jan; 48(1):58-69. PubMed ID: 25450016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
    Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
    Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model.
    Dhana K; Ikram MA; Hofman A; Franco OH; Kavousi M
    Heart; 2015 Mar; 101(5):377-83. PubMed ID: 25502814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
    Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
    Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.
    Fung TT; Chiuve SE; McCullough ML; Rexrode KM; Logroscino G; Hu FB
    Arch Intern Med; 2008 Apr; 168(7):713-20. PubMed ID: 18413553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.